refractory benign esophageal stricture
Conditions
Interventions
Esophageal stent placement Flexella-J esophageal stent
Sponsors
Kanazawa University, Graduate School of Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with refractory benign esophageal stricture who underwent a history of dilatation procedure for benign esophageal stricture after esophageal cancer and gastric cancer surgery which meets one or both of the following criteria. 1) Dysphagia score of >= 2 2) Endoscope (diameter of 9-11 mm) could not pass the stricture. 3) Non-malignant finding with endoscopic examination. 4) ECOG performance status of 0-3. 5) >= 20 years old. 6) Patients with informed concent.
Exclusion criteria
Exclusion criteria: 1) Patients with neoplastic lesions in the stenosis 2) Stenosis is in the high esophagus and the upper edge of the stent is assumed to contact with the esophageal entrance 3) Patients with a fistula in the stenosis 4) Stenosis length is more than 10cm 5) Patients with bleeding tendency 6) Patients who underwent radiation therapy 7) Women that there is a possibility of pregnancy or during pregnancy 8) Patient is judged to be inappropriate for enrollment of the study for any reason by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset rate of restenosis after esophageal stent removal | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of dysphagia score improvement at 1-month after stent removal Proportion of stricture improvement at 5-month after stent removal Occurrence rate and the types of adverse events Periods to the onset of restenosis Occurrence rate of stent slippage | — |
Countries
Japan
Contacts
Public ContactKoichi Okamoto
Kanazawa University, Graduate School of Medical Science Division of Cancer Medicine
Outcome results
None listed